Literature DB >> 32436828

Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.

Nilesh Kumar Sharma1, Jayanta K Pal1.   

Abstract

Tumor heterogeneity is influenced by various factors including genetic, epigenetic and axis of metabolic-epigenomic regulation. In recent years, metabolic-epigenomic reprogramming has been considered as one of the many tumor hallmarks and it appears to be driven by both microenvironment and macroenvironment factors including diet, microbiota and environmental pressures. Epigenetically, histone lysine residues are altered by various post-translational modifications (PTMs) such as acetylation, acylation, methylation and lactylation. Furthermore, lactylation is suggested as a new form of PTM that uses a lactate substrate as a metabolic ink for epigenetic writer enzyme that remodels histone proteins. Therefore, preclinical and clinical attempts are warranted to disrupt the pathway of metabolic-epigenomic reprogramming that will turn pro-tumor microenvironment into an anti-tumor microenvironment. This paper highlights the metabolicepigenomic regulation events including lactylation and its metabolic substrate lactate in the tumor microenvironment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; Diet; Epigenomic; Lactate; Metabolite; Microenvironment

Mesh:

Substances:

Year:  2021        PMID: 32436828     DOI: 10.2174/1566524020666200521075252

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  2 in total

Review 1.  Lactylation: a Passing Fad or the Future of Posttranslational Modification.

Authors:  Qi Xin; Hai Wang; Qinglin Li; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Inflammation       Date:  2022-02-27       Impact factor: 4.657

Review 2.  Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression.

Authors:  Lihua Chen; Lixiang Huang; Yu Gu; Wei Cang; Pengming Sun; Yang Xiang
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.